General description
This stable-labeled internal standard is suitable for use in LC/MS or GC/MS applications including forensic or clinical toxicology analysis and urine drug testing. Dehydro Aripiprazole is the primary, active metabolite of aripiprazole, marketed as the atypical antipsychotic Abilify® for the treatment of schizophrenia, bipolar disorder, and clinical depression.
Legal Information
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
CERILLIANT is a registered trademark of Cerilliant Corporation
Abilify is a registered trademark of Otsuka Pharmaceutical Co.
This product has met the following criteria: